FDA Adverse Event Injury Summary report: N

XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 5530580 · Received March 28, 2016

Report

Report Number
2024168-2016-02012
Event Type
Injury
Date Received
March 28, 2016
Date of Event
December 26, 2014
Report Date
March 28, 2016
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). LAB DATA: ON (B)(6) 2014 (06:34): CK=52 U/L, NORMAL UPPER LIMIT 200. ON (B)(6) 2014 (06:34): CK-MB=5.0 NG/ML, NORMAL UPPER LIMIT 5.0. CONCOMITANT PRODUCTS: DILATATION CATHETER: EMERGE 2.5X8, NC EUPHORA 3.75X8. (B)(4). THERE WAS NO REPORTED DEVICE MALFUNCTION AND THE PRODUCT WAS NOT RETURNED. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. DISSECTION IS LISTED IN THE XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEMS INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY STENTING PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED AND THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2014, A 3.5X15MM XIENCE ALPINE STENT WAS SUCCESSFULLY IMPLANTED IN THE DISTAL CIRCUMFLEX (CX) CORONARY ARTERY. FOLLOWING, A HAZY AREA IN THE MID CX WAS NOTED AND WAS TREATED WITH A 3.5X12MM XIENCE ALPINE STENT, RESOLVING THE DISSECTION. ANOTHER 3.5X12MM XIENCE ALPINE STENT WAS SUCCESSFULLY IMPLANTED IN THE PROXIMAL CX CORONARY ARTERY LESION. ON (B)(6) 2014, THE PATIENT WAS DISCHARGED HOME. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
186523 XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 4070841

Patients

Seq Age Sex Outcome Treatment
1 56 YR Required Intervention